Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.
Folate receptor alpha (FRalpha) has been described as a factor involved in mediating Ebola virus entry into cells (6). Furthermore, it was suggested that interaction with FRalpha results in internalization and subsequent viral ingress into the cytoplasm via caveolae (9). Descriptions of cellular receptors for Ebola virus and its entry mechanisms are of fundamental importance, particularly with the advent of vectors bearing Ebola virus glycoprotein (GP) being utilized for gene transfer into cell types such as airway epithelial cells. Thus, the ability of FRalpha to mediate efficient entry of viral pseudotypes carrying GP was investigated. We identified cell lines and primary cell types such as macrophages that were readily infected by GP pseudotypes despite lacking detectable surface FRalpha, indicating that this receptor is not essential for Ebola virus infection. Furthermore, we find that T-cell lines stably expressing FRalpha are not infectible, suggesting that FRalpha is also not sufficient to mediate entry. T-cell lines lack caveolae, the predominant route of FRalpha-mediated folate metabolism. However, the coexpression of FRalpha with caveolin-1, the major structural protein of caveolae, was not able to rescue infectivity in a T-cell line. In addition, other cell types lacking caveolae are fully infectible by GP pseudotypes. Finally, a panel of ligands to and soluble analogues of FRalpha were unable to inhibit infection on a range of cell lines, questioning the role of FRalpha as an important factor for Ebola virus entry.
Simmons
Graham
G
Department of Microbiology. Abramson Family Cancer Research Institute, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104-6076, USA.
Rennekamp
Andrew J
AJ
Chai
Ning
N
Vandenberghe
Luk H
LH
Riley
James L
JL
Bates
Paul
P
D000818:Animals; D001402:B-Lymphocytes; D002352:Carrier Proteins / Q000378:metabolism*; D021941:Caveolae / Q000821:virology*; D051242:Caveolin 1; D022461:Caveolins / Q000378:metabolism; D002460:Cell Line; D029043:Ebolavirus / Q000472:pathogenicity*; D058973:Folate Receptors, GPI-Anchored; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D011956:Receptors, Cell Surface; D011991:Receptors, Virus / Q000378:metabolism*; D013601:T-Lymphocytes; D014763:Viral Matrix Proteins / Q000235:genetics / Q000378:metabolism*
C495540:CAV1 protein, human; D002352:Carrier Proteins; D051242:Caveolin 1; D022461:Caveolins; D058973:Folate Receptors, GPI-Anchored; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D011991:Receptors, Virus; D014763:Viral Matrix Proteins; C110614:transmembrane glycoprotein, Ebola virus